nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—SLCO4C1—Methotrexate—urinary bladder cancer	0.155	0.222	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—urinary bladder cancer	0.109	0.156	CbGbCtD
Levothyroxine—ABCB1—Mitomycin—urinary bladder cancer	0.0748	0.107	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—urinary bladder cancer	0.0609	0.0869	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—urinary bladder cancer	0.0376	0.0537	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—urinary bladder cancer	0.0354	0.0506	CbGbCtD
Levothyroxine—ALB—Fluorouracil—urinary bladder cancer	0.0352	0.0503	CbGbCtD
Levothyroxine—CYP3A4—Thiotepa—urinary bladder cancer	0.034	0.0485	CbGbCtD
Levothyroxine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0272	0.0389	CbGbCtD
Levothyroxine—CYP2C8—Etoposide—urinary bladder cancer	0.0227	0.0324	CbGbCtD
Levothyroxine—ABCB1—Gemcitabine—urinary bladder cancer	0.0215	0.0308	CbGbCtD
Levothyroxine—ALB—Methotrexate—urinary bladder cancer	0.0194	0.0277	CbGbCtD
Levothyroxine—ABCB1—Cisplatin—urinary bladder cancer	0.0156	0.0223	CbGbCtD
Levothyroxine—ABCB1—Etoposide—urinary bladder cancer	0.0154	0.022	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—urinary bladder cancer	0.0105	0.015	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—urinary bladder cancer	0.0102	0.0145	CbGbCtD
Levothyroxine—CYP3A4—Etoposide—urinary bladder cancer	0.00921	0.0132	CbGbCtD
Levothyroxine—TTR—urine—urinary bladder cancer	0.00917	0.0832	CbGeAlD
Levothyroxine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00628	0.00897	CbGbCtD
Levothyroxine—THRB—prostate gland—urinary bladder cancer	0.00443	0.0402	CbGeAlD
Levothyroxine—THRA—prostate gland—urinary bladder cancer	0.00443	0.0402	CbGeAlD
Levothyroxine—SLC16A2—prostate gland—urinary bladder cancer	0.00401	0.0364	CbGeAlD
Levothyroxine—SLCO4C1—seminal vesicle—urinary bladder cancer	0.00391	0.0355	CbGeAlD
Levothyroxine—SLC7A5—prostate gland—urinary bladder cancer	0.00338	0.0307	CbGeAlD
Levothyroxine—SLCO4C1—renal system—urinary bladder cancer	0.00315	0.0286	CbGeAlD
Levothyroxine—THRA—renal system—urinary bladder cancer	0.00302	0.0274	CbGeAlD
Levothyroxine—THRB—renal system—urinary bladder cancer	0.00302	0.0274	CbGeAlD
Levothyroxine—SLCO4A1—prostate gland—urinary bladder cancer	0.00295	0.0268	CbGeAlD
Levothyroxine—SLC7A5—seminal vesicle—urinary bladder cancer	0.00286	0.0259	CbGeAlD
Levothyroxine—CYP3A4—urine—urinary bladder cancer	0.00279	0.0253	CbGeAlD
Levothyroxine—SLC16A2—urethra—urinary bladder cancer	0.00269	0.0244	CbGeAlD
Levothyroxine—SLCO1C1—renal system—urinary bladder cancer	0.00251	0.0228	CbGeAlD
Levothyroxine—SLCO4A1—seminal vesicle—urinary bladder cancer	0.0025	0.0227	CbGeAlD
Levothyroxine—SLC7A5—epithelium—urinary bladder cancer	0.00248	0.0225	CbGeAlD
Levothyroxine—THRB—female reproductive system—urinary bladder cancer	0.00242	0.0219	CbGeAlD
Levothyroxine—THRA—female reproductive system—urinary bladder cancer	0.00242	0.0219	CbGeAlD
Levothyroxine—SLC7A5—smooth muscle tissue—urinary bladder cancer	0.00239	0.0217	CbGeAlD
Levothyroxine—SLCO4C1—vagina—urinary bladder cancer	0.00228	0.0207	CbGeAlD
Levothyroxine—SLC7A5—urethra—urinary bladder cancer	0.00226	0.0205	CbGeAlD
Levothyroxine—TTR—renal system—urinary bladder cancer	0.00224	0.0204	CbGeAlD
Levothyroxine—SLCO1B3—vagina—urinary bladder cancer	0.00222	0.0201	CbGeAlD
Levothyroxine—THRB—vagina—urinary bladder cancer	0.00219	0.0198	CbGeAlD
Levothyroxine—SLCO4A1—renal system—urinary bladder cancer	0.00201	0.0183	CbGeAlD
Levothyroxine—SLC16A2—vagina—urinary bladder cancer	0.00198	0.018	CbGeAlD
Levothyroxine—SLCO4A1—urethra—urinary bladder cancer	0.00198	0.0179	CbGeAlD
Levothyroxine—SLC7A5—female reproductive system—urinary bladder cancer	0.00185	0.0167	CbGeAlD
Levothyroxine—TTR—female reproductive system—urinary bladder cancer	0.0018	0.0163	CbGeAlD
Levothyroxine—SLCO1B1—renal system—urinary bladder cancer	0.00177	0.0161	CbGeAlD
Levothyroxine—SLC7A5—vagina—urinary bladder cancer	0.00167	0.0151	CbGeAlD
Levothyroxine—SLCO4A1—female reproductive system—urinary bladder cancer	0.00161	0.0146	CbGeAlD
Levothyroxine—SLCO4A1—vagina—urinary bladder cancer	0.00146	0.0132	CbGeAlD
Levothyroxine—SLCO1A2—renal system—urinary bladder cancer	0.00144	0.0131	CbGeAlD
Levothyroxine—SLCO1B1—female reproductive system—urinary bladder cancer	0.00142	0.0129	CbGeAlD
Levothyroxine—THRB—lymph node—urinary bladder cancer	0.00141	0.0128	CbGeAlD
Levothyroxine—THRA—lymph node—urinary bladder cancer	0.00141	0.0128	CbGeAlD
Levothyroxine—SLC16A2—lymph node—urinary bladder cancer	0.00128	0.0116	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—urinary bladder cancer	0.00118	0.0107	CbGeAlD
Levothyroxine—SLC7A5—lymph node—urinary bladder cancer	0.00108	0.0098	CbGeAlD
Levothyroxine—CYP2C8—renal system—urinary bladder cancer	0.00101	0.00913	CbGeAlD
Levothyroxine—SLCO4A1—lymph node—urinary bladder cancer	0.000943	0.00855	CbGeAlD
Levothyroxine—CYP2C8—female reproductive system—urinary bladder cancer	0.000806	0.00732	CbGeAlD
Levothyroxine—Cardiac failure—Fluorouracil—urinary bladder cancer	0.000775	0.00713	CcSEcCtD
Levothyroxine—Nausea—Valrubicin—urinary bladder cancer	0.00077	0.00708	CcSEcCtD
Levothyroxine—Fatigue—Mitomycin—urinary bladder cancer	0.00077	0.00708	CcSEcCtD
Levothyroxine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000736	0.00677	CcSEcCtD
Levothyroxine—CYP2C8—vagina—urinary bladder cancer	0.000729	0.00662	CbGeAlD
Levothyroxine—Cardiac failure congestive—Etoposide—urinary bladder cancer	0.000724	0.00666	CcSEcCtD
Levothyroxine—Irritability—Fluorouracil—urinary bladder cancer	0.000722	0.00664	CcSEcCtD
Levothyroxine—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.000719	0.00661	CcSEcCtD
Levothyroxine—ABCB1—prostate gland—urinary bladder cancer	0.000708	0.00643	CbGeAlD
Levothyroxine—Body temperature increased—Mitomycin—urinary bladder cancer	0.000706	0.0065	CcSEcCtD
Levothyroxine—Irritability—Cisplatin—urinary bladder cancer	0.000684	0.00629	CcSEcCtD
Levothyroxine—CYP3A4—renal system—urinary bladder cancer	0.000682	0.00619	CbGeAlD
Levothyroxine—Cardiac failure—Etoposide—urinary bladder cancer	0.000673	0.00619	CcSEcCtD
Levothyroxine—ALB—lymph node—urinary bladder cancer	0.000671	0.00609	CbGeAlD
Levothyroxine—Muscular weakness—Fluorouracil—urinary bladder cancer	0.000667	0.00613	CcSEcCtD
Levothyroxine—Dehydration—Cisplatin—urinary bladder cancer	0.000667	0.00613	CcSEcCtD
Levothyroxine—Dysphagia—Fluorouracil—urinary bladder cancer	0.000654	0.00601	CcSEcCtD
Levothyroxine—Asthenia—Mitomycin—urinary bladder cancer	0.000641	0.0059	CcSEcCtD
Levothyroxine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.000637	0.00585	CcSEcCtD
Levothyroxine—Cardiac arrest—Etoposide—urinary bladder cancer	0.000624	0.00574	CcSEcCtD
Levothyroxine—Diarrhoea—Mitomycin—urinary bladder cancer	0.000611	0.00562	CcSEcCtD
Levothyroxine—Sweating increased—Cisplatin—urinary bladder cancer	0.000604	0.00555	CcSEcCtD
Levothyroxine—ABCB1—seminal vesicle—urinary bladder cancer	0.000599	0.00543	CbGeAlD
Levothyroxine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.000584	0.00537	CcSEcCtD
Levothyroxine—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.000581	0.00534	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.000574	0.00528	CcSEcCtD
Levothyroxine—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.000571	0.00525	CcSEcCtD
Levothyroxine—Sweating—Gemcitabine—urinary bladder cancer	0.000568	0.00523	CcSEcCtD
Levothyroxine—Vomiting—Mitomycin—urinary bladder cancer	0.000568	0.00522	CcSEcCtD
Levothyroxine—Dysphagia—Etoposide—urinary bladder cancer	0.000568	0.00522	CcSEcCtD
Levothyroxine—Arrhythmia—Thiotepa—urinary bladder cancer	0.000565	0.0052	CcSEcCtD
Levothyroxine—Rash—Mitomycin—urinary bladder cancer	0.000563	0.00518	CcSEcCtD
Levothyroxine—Dermatitis—Mitomycin—urinary bladder cancer	0.000563	0.00518	CcSEcCtD
Levothyroxine—Headache—Mitomycin—urinary bladder cancer	0.00056	0.00515	CcSEcCtD
Levothyroxine—Alopecia—Thiotepa—urinary bladder cancer	0.000559	0.00514	CcSEcCtD
Levothyroxine—Sweating increased—Etoposide—urinary bladder cancer	0.000553	0.00508	CcSEcCtD
Levothyroxine—CYP3A4—female reproductive system—urinary bladder cancer	0.000546	0.00496	CbGeAlD
Levothyroxine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.000545	0.00501	CcSEcCtD
Levothyroxine—Myocardial infarction—Cisplatin—urinary bladder cancer	0.000542	0.00498	CcSEcCtD
Levothyroxine—Tension—Thiotepa—urinary bladder cancer	0.00054	0.00497	CcSEcCtD
Levothyroxine—Nervousness—Thiotepa—urinary bladder cancer	0.000535	0.00492	CcSEcCtD
Levothyroxine—Nausea—Mitomycin—urinary bladder cancer	0.000531	0.00488	CcSEcCtD
Levothyroxine—ABCB1—epithelium—urinary bladder cancer	0.00052	0.00472	CbGeAlD
Levothyroxine—Agitation—Thiotepa—urinary bladder cancer	0.000506	0.00465	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.000499	0.00459	CcSEcCtD
Levothyroxine—Myocardial infarction—Etoposide—urinary bladder cancer	0.000496	0.00456	CcSEcCtD
Levothyroxine—Coma—Methotrexate—urinary bladder cancer	0.000495	0.00455	CcSEcCtD
Levothyroxine—ABCB1—renal system—urinary bladder cancer	0.000483	0.00438	CbGeAlD
Levothyroxine—Convulsion—Thiotepa—urinary bladder cancer	0.000477	0.00439	CcSEcCtD
Levothyroxine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000475	0.00437	CcSEcCtD
Levothyroxine—ABCB1—urethra—urinary bladder cancer	0.000474	0.0043	CbGeAlD
Levothyroxine—Alopecia—Gemcitabine—urinary bladder cancer	0.00047	0.00432	CcSEcCtD
Levothyroxine—Arthralgia—Thiotepa—urinary bladder cancer	0.000469	0.00431	CcSEcCtD
Levothyroxine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000467	0.0043	CcSEcCtD
Levothyroxine—Anxiety—Thiotepa—urinary bladder cancer	0.000467	0.0043	CcSEcCtD
Levothyroxine—Coma—Epirubicin—urinary bladder cancer	0.000463	0.00426	CcSEcCtD
Levothyroxine—Alopecia—Fluorouracil—urinary bladder cancer	0.000462	0.00425	CcSEcCtD
Levothyroxine—Flushing—Cisplatin—urinary bladder cancer	0.00046	0.00423	CcSEcCtD
Levothyroxine—Confusional state—Thiotepa—urinary bladder cancer	0.000453	0.00417	CcSEcCtD
Levothyroxine—Arrhythmia—Cisplatin—urinary bladder cancer	0.000443	0.00407	CcSEcCtD
Levothyroxine—Tachycardia—Thiotepa—urinary bladder cancer	0.000439	0.00403	CcSEcCtD
Levothyroxine—Alopecia—Cisplatin—urinary bladder cancer	0.000438	0.00403	CcSEcCtD
Levothyroxine—Coma—Doxorubicin—urinary bladder cancer	0.000429	0.00394	CcSEcCtD
Levothyroxine—Flushing—Etoposide—urinary bladder cancer	0.000422	0.00388	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000409	0.00376	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.000406	0.00373	CcSEcCtD
Levothyroxine—Tremor—Cisplatin—urinary bladder cancer	0.000404	0.00372	CcSEcCtD
Levothyroxine—Alopecia—Etoposide—urinary bladder cancer	0.000401	0.00369	CcSEcCtD
Levothyroxine—Convulsion—Fluorouracil—urinary bladder cancer	0.000395	0.00363	CcSEcCtD
Levothyroxine—Arthralgia—Gemcitabine—urinary bladder cancer	0.000394	0.00363	CcSEcCtD
Levothyroxine—Increased appetite—Epirubicin—urinary bladder cancer	0.000392	0.0036	CcSEcCtD
Levothyroxine—Fatigue—Thiotepa—urinary bladder cancer	0.000387	0.00356	CcSEcCtD
Levothyroxine—ABCB1—female reproductive system—urinary bladder cancer	0.000387	0.00351	CbGeAlD
Levothyroxine—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.000377	0.00347	CcSEcCtD
Levothyroxine—Cardiac failure—Epirubicin—urinary bladder cancer	0.000377	0.00347	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.000376	0.00345	CcSEcCtD
Levothyroxine—Irritability—Methotrexate—urinary bladder cancer	0.000375	0.00345	CcSEcCtD
Levothyroxine—Confusional state—Fluorouracil—urinary bladder cancer	0.000375	0.00345	CcSEcCtD
Levothyroxine—Convulsion—Cisplatin—urinary bladder cancer	0.000374	0.00344	CcSEcCtD
Levothyroxine—Mood swings—Methotrexate—urinary bladder cancer	0.000373	0.00343	CcSEcCtD
Levothyroxine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00037	0.00341	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000367	0.00338	CcSEcCtD
Levothyroxine—Anxiety—Cisplatin—urinary bladder cancer	0.000366	0.00337	CcSEcCtD
Levothyroxine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000365	0.00336	CcSEcCtD
Levothyroxine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000363	0.00334	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—urinary bladder cancer	0.000363	0.00333	CcSEcCtD
Levothyroxine—Affect lability—Epirubicin—urinary bladder cancer	0.000362	0.00333	CcSEcCtD
Levothyroxine—Urticaria—Thiotepa—urinary bladder cancer	0.000357	0.00328	CcSEcCtD
Levothyroxine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000355	0.00327	CcSEcCtD
Levothyroxine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000355	0.00327	CcSEcCtD
Levothyroxine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00035	0.00322	CcSEcCtD
Levothyroxine—ABCB1—vagina—urinary bladder cancer	0.00035	0.00317	CbGeAlD
Levothyroxine—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000349	0.00321	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—urinary bladder cancer	0.000349	0.00321	CcSEcCtD
Levothyroxine—Mood swings—Epirubicin—urinary bladder cancer	0.000349	0.00321	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000344	0.00317	CcSEcCtD
Levothyroxine—Tachycardia—Cisplatin—urinary bladder cancer	0.000344	0.00316	CcSEcCtD
Levothyroxine—Convulsion—Etoposide—urinary bladder cancer	0.000343	0.00315	CcSEcCtD
Levothyroxine—Dehydration—Epirubicin—urinary bladder cancer	0.000342	0.00315	CcSEcCtD
Levothyroxine—Insomnia—Gemcitabine—urinary bladder cancer	0.000342	0.00314	CcSEcCtD
Levothyroxine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000341	0.00313	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000339	0.00311	CcSEcCtD
Levothyroxine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000337	0.0031	CcSEcCtD
Levothyroxine—Insomnia—Fluorouracil—urinary bladder cancer	0.000336	0.00309	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—urinary bladder cancer	0.000335	0.00308	CcSEcCtD
Levothyroxine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000331	0.00305	CcSEcCtD
Levothyroxine—Fatigue—Gemcitabine—urinary bladder cancer	0.000326	0.003	CcSEcCtD
Levothyroxine—Confusional state—Etoposide—urinary bladder cancer	0.000325	0.00299	CcSEcCtD
Levothyroxine—Muscular weakness—Epirubicin—urinary bladder cancer	0.000325	0.00299	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000324	0.00298	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—urinary bladder cancer	0.000323	0.00297	CcSEcCtD
Levothyroxine—Asthenia—Thiotepa—urinary bladder cancer	0.000322	0.00296	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000321	0.00295	CcSEcCtD
Levothyroxine—Dysphagia—Epirubicin—urinary bladder cancer	0.000318	0.00293	CcSEcCtD
Levothyroxine—Pruritus—Thiotepa—urinary bladder cancer	0.000318	0.00292	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—urinary bladder cancer	0.000317	0.00291	CcSEcCtD
Levothyroxine—Tachycardia—Etoposide—urinary bladder cancer	0.000315	0.0029	CcSEcCtD
Levothyroxine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000314	0.00289	CcSEcCtD
Levothyroxine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000312	0.00287	CcSEcCtD
Levothyroxine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000312	0.00286	CcSEcCtD
Levothyroxine—Angina pectoris—Epirubicin—urinary bladder cancer	0.00031	0.00285	CcSEcCtD
Levothyroxine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000307	0.00283	CcSEcCtD
Levothyroxine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000306	0.00282	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.0003	0.00276	CcSEcCtD
Levothyroxine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000299	0.00275	CcSEcCtD
Levothyroxine—Urticaria—Fluorouracil—urinary bladder cancer	0.000295	0.00272	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000294	0.00271	CcSEcCtD
Levothyroxine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000294	0.0027	CcSEcCtD
Levothyroxine—Sweating—Methotrexate—urinary bladder cancer	0.000291	0.00267	CcSEcCtD
Levothyroxine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00029	0.00267	CcSEcCtD
Levothyroxine—Weight decreased—Epirubicin—urinary bladder cancer	0.000288	0.00265	CcSEcCtD
Levothyroxine—Dyspnoea—Etoposide—urinary bladder cancer	0.000288	0.00265	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000287	0.00264	CcSEcCtD
Levothyroxine—Vomiting—Thiotepa—urinary bladder cancer	0.000286	0.00263	CcSEcCtD
Levothyroxine—Rash—Thiotepa—urinary bladder cancer	0.000283	0.00261	CcSEcCtD
Levothyroxine—Dermatitis—Thiotepa—urinary bladder cancer	0.000283	0.0026	CcSEcCtD
Levothyroxine—Headache—Thiotepa—urinary bladder cancer	0.000282	0.00259	CcSEcCtD
Levothyroxine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000279	0.00256	CcSEcCtD
Levothyroxine—Fatigue—Etoposide—urinary bladder cancer	0.000278	0.00256	CcSEcCtD
Levothyroxine—Sweating—Epirubicin—urinary bladder cancer	0.000272	0.0025	CcSEcCtD
Levothyroxine—Asthenia—Gemcitabine—urinary bladder cancer	0.000271	0.00249	CcSEcCtD
Levothyroxine—Pruritus—Gemcitabine—urinary bladder cancer	0.000267	0.00246	CcSEcCtD
Levothyroxine—Nausea—Thiotepa—urinary bladder cancer	0.000267	0.00245	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—urinary bladder cancer	0.000266	0.00245	CcSEcCtD
Levothyroxine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000266	0.00245	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000264	0.00243	CcSEcCtD
Levothyroxine—Pruritus—Fluorouracil—urinary bladder cancer	0.000263	0.00242	CcSEcCtD
Levothyroxine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000259	0.00238	CcSEcCtD
Levothyroxine—Urticaria—Etoposide—urinary bladder cancer	0.000256	0.00236	CcSEcCtD
Levothyroxine—Abdominal pain—Etoposide—urinary bladder cancer	0.000255	0.00235	CcSEcCtD
Levothyroxine—Body temperature increased—Etoposide—urinary bladder cancer	0.000255	0.00235	CcSEcCtD
Levothyroxine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000254	0.00234	CcSEcCtD
Levothyroxine—Asthenia—Cisplatin—urinary bladder cancer	0.000253	0.00232	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—urinary bladder cancer	0.000252	0.00231	CcSEcCtD
Levothyroxine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000241	0.00222	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—urinary bladder cancer	0.00024	0.00221	CcSEcCtD
Levothyroxine—Vomiting—Gemcitabine—urinary bladder cancer	0.00024	0.00221	CcSEcCtD
Levothyroxine—Rash—Gemcitabine—urinary bladder cancer	0.000238	0.00219	CcSEcCtD
Levothyroxine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000238	0.00219	CcSEcCtD
Levothyroxine—Headache—Gemcitabine—urinary bladder cancer	0.000237	0.00218	CcSEcCtD
Levothyroxine—Flushing—Epirubicin—urinary bladder cancer	0.000236	0.00217	CcSEcCtD
Levothyroxine—Vomiting—Fluorouracil—urinary bladder cancer	0.000236	0.00217	CcSEcCtD
Levothyroxine—Rash—Fluorouracil—urinary bladder cancer	0.000234	0.00215	CcSEcCtD
Levothyroxine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000234	0.00215	CcSEcCtD
Levothyroxine—Headache—Fluorouracil—urinary bladder cancer	0.000233	0.00214	CcSEcCtD
Levothyroxine—Asthenia—Etoposide—urinary bladder cancer	0.000232	0.00213	CcSEcCtD
Levothyroxine—Pruritus—Etoposide—urinary bladder cancer	0.000228	0.0021	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000228	0.00209	CcSEcCtD
Levothyroxine—ABCB1—lymph node—urinary bladder cancer	0.000226	0.00205	CbGeAlD
Levothyroxine—Alopecia—Epirubicin—urinary bladder cancer	0.000225	0.00207	CcSEcCtD
Levothyroxine—Nausea—Gemcitabine—urinary bladder cancer	0.000225	0.00206	CcSEcCtD
Levothyroxine—Vomiting—Cisplatin—urinary bladder cancer	0.000224	0.00206	CcSEcCtD
Levothyroxine—Rash—Cisplatin—urinary bladder cancer	0.000222	0.00204	CcSEcCtD
Levothyroxine—Dermatitis—Cisplatin—urinary bladder cancer	0.000222	0.00204	CcSEcCtD
Levothyroxine—Diarrhoea—Etoposide—urinary bladder cancer	0.000221	0.00203	CcSEcCtD
Levothyroxine—Nausea—Fluorouracil—urinary bladder cancer	0.000221	0.00203	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—urinary bladder cancer	0.000219	0.00201	CcSEcCtD
Levothyroxine—Tension—Epirubicin—urinary bladder cancer	0.000218	0.002	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—urinary bladder cancer	0.000215	0.00198	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000211	0.00194	CcSEcCtD
Levothyroxine—Nausea—Cisplatin—urinary bladder cancer	0.000209	0.00192	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—urinary bladder cancer	0.000208	0.00191	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—urinary bladder cancer	0.000205	0.00189	CcSEcCtD
Levothyroxine—Vomiting—Etoposide—urinary bladder cancer	0.000205	0.00189	CcSEcCtD
Levothyroxine—Agitation—Epirubicin—urinary bladder cancer	0.000204	0.00187	CcSEcCtD
Levothyroxine—Rash—Etoposide—urinary bladder cancer	0.000204	0.00187	CcSEcCtD
Levothyroxine—Dermatitis—Etoposide—urinary bladder cancer	0.000203	0.00187	CcSEcCtD
Levothyroxine—Headache—Etoposide—urinary bladder cancer	0.000202	0.00186	CcSEcCtD
Levothyroxine—Arthralgia—Methotrexate—urinary bladder cancer	0.000202	0.00185	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—urinary bladder cancer	0.000201	0.00185	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—urinary bladder cancer	0.000199	0.00183	CcSEcCtD
Levothyroxine—Palpitations—Epirubicin—urinary bladder cancer	0.000196	0.0018	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—urinary bladder cancer	0.000195	0.00179	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—urinary bladder cancer	0.000192	0.00177	CcSEcCtD
Levothyroxine—Nausea—Etoposide—urinary bladder cancer	0.000192	0.00176	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—urinary bladder cancer	0.000189	0.00174	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—urinary bladder cancer	0.000189	0.00173	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—urinary bladder cancer	0.000188	0.00173	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000187	0.00172	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—urinary bladder cancer	0.000182	0.00168	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—urinary bladder cancer	0.000181	0.00167	CcSEcCtD
Levothyroxine—Shock—Epirubicin—urinary bladder cancer	0.000178	0.00164	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—urinary bladder cancer	0.000178	0.00163	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—urinary bladder cancer	0.000177	0.00162	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000176	0.00162	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000175	0.00161	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—urinary bladder cancer	0.000175	0.00161	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000175	0.00161	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—urinary bladder cancer	0.000174	0.0016	CcSEcCtD
Levothyroxine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000172	0.00159	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—urinary bladder cancer	0.000169	0.00155	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—urinary bladder cancer	0.000167	0.00153	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000165	0.00152	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—urinary bladder cancer	0.000165	0.00151	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—urinary bladder cancer	0.000164	0.0015	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000163	0.0015	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000162	0.00149	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000161	0.00148	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000159	0.00147	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000158	0.00145	CcSEcCtD
Levothyroxine—Fatigue—Epirubicin—urinary bladder cancer	0.000156	0.00143	CcSEcCtD
Levothyroxine—Urticaria—Methotrexate—urinary bladder cancer	0.000154	0.00141	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000153	0.00141	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000153	0.00141	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000153	0.0014	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—urinary bladder cancer	0.000151	0.00139	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000149	0.00137	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000149	0.00137	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000148	0.00136	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—urinary bladder cancer	0.000144	0.00133	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—urinary bladder cancer	0.000144	0.00132	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000143	0.00132	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000143	0.00132	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—urinary bladder cancer	0.000139	0.00128	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000138	0.00127	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000137	0.00126	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—urinary bladder cancer	0.000137	0.00126	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—urinary bladder cancer	0.000133	0.00122	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000132	0.00122	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000132	0.00122	CcSEcCtD
Levothyroxine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000132	0.00122	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—urinary bladder cancer	0.00013	0.00119	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—urinary bladder cancer	0.000128	0.00118	CcSEcCtD
Levothyroxine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000124	0.00114	CcSEcCtD
Levothyroxine—Vomiting—Methotrexate—urinary bladder cancer	0.000123	0.00113	CcSEcCtD
Levothyroxine—Rash—Methotrexate—urinary bladder cancer	0.000122	0.00112	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—urinary bladder cancer	0.000122	0.00112	CcSEcCtD
Levothyroxine—Headache—Methotrexate—urinary bladder cancer	0.000121	0.00111	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—urinary bladder cancer	0.00012	0.0011	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—urinary bladder cancer	0.000118	0.00109	CcSEcCtD
Levothyroxine—Vomiting—Epirubicin—urinary bladder cancer	0.000115	0.00106	CcSEcCtD
Levothyroxine—Nausea—Methotrexate—urinary bladder cancer	0.000115	0.00106	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000115	0.00105	CcSEcCtD
Levothyroxine—Rash—Epirubicin—urinary bladder cancer	0.000114	0.00105	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—urinary bladder cancer	0.000114	0.00105	CcSEcCtD
Levothyroxine—Headache—Epirubicin—urinary bladder cancer	0.000113	0.00104	CcSEcCtD
Levothyroxine—Nausea—Epirubicin—urinary bladder cancer	0.000107	0.000988	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—urinary bladder cancer	0.000106	0.000979	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—urinary bladder cancer	0.000106	0.000971	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000105	0.00097	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—urinary bladder cancer	0.000105	0.000964	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—urinary bladder cancer	9.94e-05	0.000914	CcSEcCtD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.96e-05	0.000489	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.94e-05	0.000486	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.94e-05	0.000486	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	3.88e-05	0.000478	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	3.84e-05	0.000474	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NCOR1—urinary bladder cancer	3.81e-05	0.00047	CbGpPWpGaD
Levothyroxine—TTR—Disease—CREBBP—urinary bladder cancer	3.75e-05	0.000462	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.73e-05	0.000459	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.7e-05	0.000457	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	3.69e-05	0.000455	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—NQO1—urinary bladder cancer	3.69e-05	0.000455	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.67e-05	0.000453	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—UGT2B7—urinary bladder cancer	3.67e-05	0.000452	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	3.59e-05	0.000443	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	3.59e-05	0.000443	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.58e-05	0.000441	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.57e-05	0.00044	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	3.53e-05	0.000435	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.52e-05	0.000434	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.51e-05	0.000433	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.51e-05	0.000433	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	3.48e-05	0.00043	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.47e-05	0.000428	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.43e-05	0.000423	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	3.42e-05	0.000422	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.41e-05	0.00042	CbGpPWpGaD
Levothyroxine—TTR—Disease—RHOA—urinary bladder cancer	3.39e-05	0.000418	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.38e-05	0.000416	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—MYC—urinary bladder cancer	3.36e-05	0.000415	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—MYC—urinary bladder cancer	3.36e-05	0.000415	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TERT—urinary bladder cancer	3.36e-05	0.000415	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	3.32e-05	0.000409	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	3.32e-05	0.000409	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP4B1—urinary bladder cancer	3.3e-05	0.000407	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.26e-05	0.000402	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	3.23e-05	0.000399	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.21e-05	0.000396	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IFNA2—urinary bladder cancer	3.15e-05	0.000388	CbGpPWpGaD
Levothyroxine—TTR—Disease—ERBB2—urinary bladder cancer	3.14e-05	0.000387	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	3.13e-05	0.000387	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.12e-05	0.000385	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC19A1—urinary bladder cancer	3.12e-05	0.000384	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—FGFR3—urinary bladder cancer	3.09e-05	0.00038	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GSTP1—urinary bladder cancer	3.07e-05	0.000379	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	3.07e-05	0.000379	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	3.07e-05	0.000379	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTGS2—urinary bladder cancer	3.07e-05	0.000379	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	3.05e-05	0.000377	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.05e-05	0.000377	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PRSS3—urinary bladder cancer	3.04e-05	0.000375	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ESR1—urinary bladder cancer	3e-05	0.00037	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.98e-05	0.000368	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	2.98e-05	0.000367	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.97e-05	0.000367	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.95e-05	0.000363	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.93e-05	0.000362	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	2.9e-05	0.000357	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.89e-05	0.000357	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.88e-05	0.000355	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	2.86e-05	0.000352	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	2.82e-05	0.000348	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	2.82e-05	0.000348	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.81e-05	0.000346	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.79e-05	0.000344	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.73e-05	0.000337	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.71e-05	0.000334	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	2.71e-05	0.000334	CbGpPWpGaD
Levothyroxine—TTR—Disease—CDKN1A—urinary bladder cancer	2.68e-05	0.000331	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTEN—urinary bladder cancer	2.68e-05	0.00033	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.66e-05	0.000328	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	2.66e-05	0.000328	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CREBBP—urinary bladder cancer	2.63e-05	0.000324	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.6e-05	0.000321	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IGF1—urinary bladder cancer	2.59e-05	0.00032	CbGpPWpGaD
Levothyroxine—TTR—Disease—EP300—urinary bladder cancer	2.55e-05	0.000315	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.52e-05	0.00031	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.51e-05	0.00031	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	2.5e-05	0.000308	CbGpPWpGaD
Levothyroxine—TTR—Disease—SRC—urinary bladder cancer	2.48e-05	0.000306	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	2.48e-05	0.000305	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.45e-05	0.000302	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.45e-05	0.000302	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	2.44e-05	0.000301	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.44e-05	0.0003	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMP—urinary bladder cancer	2.43e-05	0.000299	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.42e-05	0.000298	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.4e-05	0.000296	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.4e-05	0.000295	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RHOA—urinary bladder cancer	2.38e-05	0.000293	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	2.37e-05	0.000292	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.35e-05	0.000289	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.34e-05	0.000288	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.33e-05	0.000288	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.33e-05	0.000287	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.28e-05	0.000281	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.25e-05	0.000277	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PLAU—urinary bladder cancer	2.23e-05	0.000275	CbGpPWpGaD
Levothyroxine—TTR—Disease—MYC—urinary bladder cancer	2.23e-05	0.000274	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.22e-05	0.000274	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.22e-05	0.000274	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	2.21e-05	0.000272	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ERBB2—urinary bladder cancer	2.2e-05	0.000271	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NAT2—urinary bladder cancer	2.2e-05	0.000271	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—urinary bladder cancer	2.18e-05	0.000268	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.16e-05	0.000267	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.16e-05	0.000267	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.13e-05	0.000262	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	2.13e-05	0.000262	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.1e-05	0.000258	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.09e-05	0.000257	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	2.09e-05	0.000257	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL8—urinary bladder cancer	2.09e-05	0.000257	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	2.07e-05	0.000255	CbGpPWpGaD
Levothyroxine—TTR—Disease—KRAS—urinary bladder cancer	2.06e-05	0.000254	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.04e-05	0.000252	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	2.02e-05	0.00025	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2e-05	0.000246	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL2—urinary bladder cancer	1.99e-05	0.000246	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.98e-05	0.000244	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.96e-05	0.000242	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	1.94e-05	0.00024	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.94e-05	0.00024	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—urinary bladder cancer	1.94e-05	0.00024	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.93e-05	0.000238	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.92e-05	0.000237	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	1.92e-05	0.000237	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.91e-05	0.000235	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	1.9e-05	0.000234	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	1.9e-05	0.000234	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—RRM2—urinary bladder cancer	1.9e-05	0.000234	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—urinary bladder cancer	1.89e-05	0.000233	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1A—urinary bladder cancer	1.88e-05	0.000232	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTEN—urinary bladder cancer	1.88e-05	0.000231	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.84e-05	0.000227	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IGF1—urinary bladder cancer	1.82e-05	0.000224	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.82e-05	0.000224	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EP300—urinary bladder cancer	1.79e-05	0.000221	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.78e-05	0.00022	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.78e-05	0.00022	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.77e-05	0.000218	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.77e-05	0.000218	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HPGDS—urinary bladder cancer	1.76e-05	0.000216	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ENO2—urinary bladder cancer	1.76e-05	0.000216	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.76e-05	0.000216	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—urinary bladder cancer	1.75e-05	0.000216	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.75e-05	0.000215	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SRC—urinary bladder cancer	1.74e-05	0.000214	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.71e-05	0.000211	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.71e-05	0.000211	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTT1—urinary bladder cancer	1.7e-05	0.00021	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.69e-05	0.000208	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.68e-05	0.000207	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.68e-05	0.000207	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.68e-05	0.000207	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RHOA—urinary bladder cancer	1.67e-05	0.000205	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.66e-05	0.000205	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.64e-05	0.000202	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.59e-05	0.000197	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	1.59e-05	0.000196	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.59e-05	0.000196	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—urinary bladder cancer	1.56e-05	0.000192	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.54e-05	0.00019	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.54e-05	0.00019	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.53e-05	0.000188	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—urinary bladder cancer	1.52e-05	0.000188	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.49e-05	0.000184	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—urinary bladder cancer	1.44e-05	0.000178	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.42e-05	0.000175	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NQO1—urinary bladder cancer	1.41e-05	0.000174	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—urinary bladder cancer	1.4e-05	0.000172	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.4e-05	0.000172	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	1.39e-05	0.000171	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.38e-05	0.00017	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.37e-05	0.000169	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	1.36e-05	0.000168	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—EP300—urinary bladder cancer	1.32e-05	0.000163	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.31e-05	0.000162	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	1.31e-05	0.000161	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—urinary bladder cancer	1.28e-05	0.000158	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—EP300—urinary bladder cancer	1.25e-05	0.000155	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.25e-05	0.000154	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.24e-05	0.000153	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—urinary bladder cancer	1.22e-05	0.000151	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SRC—urinary bladder cancer	1.22e-05	0.00015	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.2e-05	0.000148	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.2e-05	0.000148	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.19e-05	0.000146	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.19e-05	0.000146	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTP1—urinary bladder cancer	1.18e-05	0.000146	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.15e-05	0.000142	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.14e-05	0.000141	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.1e-05	0.000136	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMS—urinary bladder cancer	1.1e-05	0.000135	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.09e-05	0.000135	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.09e-05	0.000134	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.09e-05	0.000134	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTM1—urinary bladder cancer	1.08e-05	0.000134	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NCOR1—urinary bladder cancer	1.08e-05	0.000134	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	1.07e-05	0.000132	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.04e-05	0.000129	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.04e-05	0.000128	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GPX1—urinary bladder cancer	1.04e-05	0.000128	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.03e-05	0.000128	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.03e-05	0.000126	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.02e-05	0.000126	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ERCC2—urinary bladder cancer	1.02e-05	0.000126	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—urinary bladder cancer	1.01e-05	0.000125	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	9.64e-06	0.000119	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMS—urinary bladder cancer	9.61e-06	0.000119	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MTHFR—urinary bladder cancer	9.58e-06	0.000118	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	9.5e-06	0.000117	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	9.5e-06	0.000117	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	9.48e-06	0.000117	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	9.48e-06	0.000117	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	9.33e-06	0.000115	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.19e-06	0.000113	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.1e-06	0.000112	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—urinary bladder cancer	8.97e-06	0.000111	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	8.93e-06	0.00011	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—EP300—urinary bladder cancer	8.9e-06	0.00011	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—urinary bladder cancer	8.58e-06	0.000106	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.4e-06	0.000104	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	7.82e-06	9.64e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARG—urinary bladder cancer	7.77e-06	9.58e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.64e-06	9.42e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	7.51e-06	9.26e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CREBBP—urinary bladder cancer	7.47e-06	9.21e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARG—urinary bladder cancer	6.81e-06	8.4e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.54e-06	8.07e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.37e-06	7.86e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	6.15e-06	7.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—urinary bladder cancer	6.11e-06	7.54e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.92e-06	7.3e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.85e-06	7.22e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.85e-06	7.22e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.61e-06	6.91e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.5e-06	6.79e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	5.36e-06	6.61e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.36e-06	6.61e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—urinary bladder cancer	5.33e-06	6.57e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.17e-06	6.38e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—EP300—urinary bladder cancer	5.11e-06	6.31e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—EP300—urinary bladder cancer	5.08e-06	6.27e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.67e-06	5.76e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.46e-06	5.49e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.2e-06	5.17e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.03e-06	4.97e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.3e-06	4.07e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.88e-06	3.55e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.74e-06	3.38e-05	CbGpPWpGaD
